XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Adoption of ASU 2022-02
Class A Common Stock
Common stock
Common stock
Class A Common Stock
Retained earnings
Retained earnings
Adoption of ASU 2022-02
Accumulated other comprehensive (loss) income
Beginning balance (in shares) at Dec. 31, 2022         44,061,244      
Beginning balance at Dec. 31, 2022 $ 811,033 $ 676   $ 330,854   $ 572,497 $ 676 $ (92,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 398         398    
Other comprehensive income (loss) 7,923             7,923
Issuance of restricted stock (in shares)         162,874      
Tax withholding related to vesting of restricted stock and other (3,353)     (3,353)        
Employee stock purchase program (in shares)         31,059      
Employee stock purchase program 631     631        
Stock option exercises (in shares)         35,663      
Stock option exercises 367     367        
Stock option based compensation expense 133     133        
Restricted stock compensation expense 6,040     6,040        
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 286         286    
Cash dividends (1,327)         (1,327)    
Ending balance (in shares) at Mar. 31, 2023         44,290,840      
Ending balance at Mar. 31, 2023 822,807     334,672   572,530   (84,395)
Beginning balance (in shares) at Dec. 31, 2023     44,617,673   44,617,673      
Beginning balance at Dec. 31, 2023 902,666     344,568   642,817   (84,719)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 27,586         27,586    
Other comprehensive income (loss) (6,518)             (6,518)
Issuance of restricted stock (in shares)         123,670      
Tax withholding related to vesting of restricted stock and other (3,057)     (3,057)        
Employee stock purchase program (in shares)         18,485      
Employee stock purchase program 702     702        
Stock option exercises (in shares)         178,845      
Stock option exercises 1,129     1,129        
Restricted stock compensation expense 6,306     6,306        
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 249         249    
Cash dividends (1,345)         (1,345)    
Ending balance (in shares) at Mar. 31, 2024     44,938,673   44,938,673      
Ending balance at Mar. 31, 2024 $ 927,718     $ 349,648   $ 669,307   $ (91,237)